Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. J. Pharm. Sci. (Online) ; 58: e20607, 2022. tab, graf
Article in English | LILACS | ID: biblio-1420427

ABSTRACT

Abstract The main aim of the paper is to assess whether vitamin C, vitamin D, and natural honey can be administered in the course of the COVID-19 pandemic for promising in line methods with recent evidence. Both systematic literature and clinical trial identification were conducted by searching various databases. A total 58 articles and 29 clinical trials were selected wherein 11 for vitamin C, 16 for vitamin D, and 2 for natural honey were identified for analysis. The high doses of vitamin C (i.e. '200 mg/kg body weight/day, divided into 4 doses') has been found to reduce COVID-19 lung damage, various flu infections. Additionally, the high doses of vitamin C can shorten around 7.8% stay in the intensive care unit. At the same time, vitamin D can effectively protect from lung injury and acute respiratory infections whereas vitamin D deficiency severely affects 75% of the institutionalized people (serum 25(OH) D < 25 nmol/L). Meanwhile, natural honey which contains proteins (0.1-0.4%); ash (0.2%); water (15-17%) has potential antiviral effects and the ability to improve immunity. Therefore, the administration of vitamins and honey is the promising evidence-based approach for reducing fatalities, saving lives, and bringing the COVID-19 pandemic to a rapid end. It is believed that the utilization of vitamin C, vitamin D, and natural honey with the current treatment may be effective in treating COVID-19-caused fatal complications such as pneumonia. Therefore, high-level clinical studies are required on COVID-19 to administrate the effects of vitamins and natural honey


Subject(s)
Vitamins/adverse effects , COVID-19 Drug Treatment/classification , Honey/adverse effects , Antiviral Agents/administration & dosage , Pneumonia/complications , Ascorbic Acid/adverse effects , Vitamin D/adverse effects , COVID-19/prevention & control
2.
Vitae (Medellín) ; 28(3): 1-12, 2021-08-11. Ilustraciones
Article in English | LILACS, COLNAL | ID: biblio-1363268

ABSTRACT

Background:Lotus arabicus L and Lotusglaber Mill. belong to the family Fabaceae, and they grow in the wild in Egypt and have different therapeutic uses in folk medicine. Objectives: This study aimed to evaluate the phytochemical profile, antimicrobial and antiviral properties of the methanolic extracts of two Lotus spp. growing in Egypt, L. arabicus and L. glaber.Material and methods: Gas chromatography-mass spectrometry was used to identify the compounds of the extracts of two Lotus species. An MTT colorimetric assay and the disc diffusion method were performed to investigate the antiviral and antimicrobial activities of two lotus species, respectively. Results: The n-hexane and methanol extracts of L. arabicuscontained high percentages of alkane hydrocarbons, such as 5-methyloctadecane, while L. glaber contained dodecane. The major compounds in the methanol extract of L. arabicuswere hexadecanoic acid methyl ester and dodecanoic acid,2,3-bis(acetyloxy)propyl ester. The major compounds in the methanol extract of L. glaber were palmitic acid and lucenin 2. The indole alkaloid ditaine was found only in L. arabicus. This alkaloid was identified for the first time in the genus Lotus. The antimicrobial properties of the extracts of the two Lotus species showed that the n-hexane extract of both Lotus species may have potential antifungal activity against Candida parapsilosis and Aspergillus flavus. Moreover, the methanolic extracts of both Lotus species have potential antiviral activity against the coxsackie B virus, but only the L. arabicus extract showed activity against the hepatitis A virus. Conclusion:Lotus arabicus might have potential antifungal or antiviral activity greater than L. glaber


Antecedentes:Lotus arabicus L y Lotus glaber Mill. pertenecen a la familia de las fabáceas y crecen en estado silvestre en Egipto y tienen diferentes usos terapéuticos en la medicina popular. Objetivos: El objetivo de este estudio es evaluar el perfil fitoquímico y las propiedades antimicrobianas de los extractos metanólicos de dos especies de Lotus que crecen en Egipto, L. arabicus y L. glaber. Material y métodos: Se utilizó la cromatografía de gases-espectrometría de masas para identificar los compuestos de los extractos de las dos especies de Lotus. Se realizó un ensayo colorimétrico MTT y el método de difusión en disco para investigar las actividades antiviral y antimicrobiana de las dos especies de Lotus, respectivamente. Resultados: Los extractos de n-hexano y metanol de L. arabicus contenían altos porcentajes de hidrocarburos alcanos, como el 5-metiloctadecano, mientras que L. glaber contenía dodecano. Los principales compuestos del extracto de metanol de L. arabicus eran el éster metílico del ácido hexadecanoico y el éster dodecanoico, 2,3-bis(acetiloxi)propilo. Los principales compuestos del extracto de metanol de L. glaber fueron el ácido palmítico y la lucenina 2. El alcaloide indólico ditaína sólo se encontró en L. arabicus. Este alcaloide fue identificado por primera vez en el género Lotus. Las propiedades antimicrobianas de los extractos de las dos especies de Lotus mostraron que el extracto n-hexano de ambas especies de Lotus puede tener una potencial actividad antifúngica contra Candidaparapsilosis y Aspergillus flavus. Además, los extractos metanólicos de ambas especies de Lotustienen una potencial actividad antiviral contra el virus coxsackie B, pero sólo el extracto de L. arabicus mostró actividad contra el virus de la hepatitis A. Conclusión: L. arabicus puede tener una potencial actividad antifúngica o antiviral mayor que L. glaber


Subject(s)
Humans , Phytochemicals , Therapeutic Uses , Anti-Infective Agents
3.
Asian Pacific Journal of Tropical Biomedicine ; (12): 327-334, 2021.
Article in Chinese | WPRIM | ID: wpr-950232

ABSTRACT

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is a novel coronavirus identified at the end of 2019. It is recognized as the causative agent of coronavirus disease 2019 (COVID-19). Flavonoids have been shown to exhibit therapeutical effect on complications related to COVID-19. The present study reviews possible therapeutic benefits of flavonoids on SARS-CoV-2. The Web of Science, PubMed, Scopus, and Google Scholar were searched using keywords: 'COVID-19', 'SARS-CoV-2', 'Kaempferol' and 'Quercetin' in the Title/Abstract. Relevant published articles in the English language until August 2020 were considered. Kaempferol and quercetin showed antiviral properties such as inhibition of protein kinase B and phosphorylation of protein kinase and blocking effects on a selective channel (3a channel) expressed in SARS-CoV infected cells. They also reduced the level of reactive oxygen species, expression of inducible nitric oxide synthase, pro-inflammatory mediators including TNF-α, IL-1α, IL-1β, IL-6, IL-10, and IL-12 p70, and chemokines. Kaempferol and quercetin might exert beneficial effects in the control or treatment of COVID-19 because of their antiviral, antioxidant, anti-inflammatory, and immunomodulatory effects.

4.
Journal of Bacteriology and Virology ; : 199-206, 2010.
Article in English | WPRIM | ID: wpr-69383

ABSTRACT

Foot-and-mouth disease (FMD) is an economically significant animal disease because of the speed of its transmission. Routine vaccination may not be effective for early protection in an outbreak situation. Small interfering RNA (siRNA) can be used as a rapid, effective, and an alternative antiviral approach. In this study, we screened 15 synthetic siRNAs to inhibit FMD virus replication in IBRS-2 cells and selected 10 siRNA sequences. Furthermore, we produced 7 adenoviruses expressing shRNA targeting conserved regions of FMDV, such as a leader sequence and nonstructural protein regions, and showed their antiviral effects. We compared the antiviral effects among them and compared between synthetic siRNAs and adenovirus-delivered siRNAs. In particular, the most efficient siRNA, 3C2, was the conserved sequence in the O, A, Asia 1, and C serotypes of FMDV and was located in the predicted loop structure. The pool of sequences including 3C2 and recombinant adenoviruses could be applied for multiple siRNAs and protection in a broad range of cells and animals.


Subject(s)
Animals , Adenoviridae , Asia , Conserved Sequence , Foot-and-Mouth Disease , Foot-and-Mouth Disease Virus , RNA , RNA, Small Interfering , Vaccination , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL